SIRT5 anticorps (C-Term)
Aperçu rapide pour SIRT5 anticorps (C-Term) (ABIN629582)
Antigène
Voir toutes SIRT5 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- SIRT5 antibody was raised against the C terminal of SIRT5
-
Purification
- Purified
-
Immunogène
- SIRT5 antibody was raised using the C terminal of SIRT5 corresponding to a region with amino acids HCDLCLVVGTSSVVYPAAMFAPQVAARGVPVAEFNTETTPATNRFSHLIS
-
-
-
-
Indications d'application
-
WB: 5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
SIRT5 Blocking Peptide, (ABIN939084), is also available for use as a blocking control in assays to test for specificity of this SIRT5 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SIRT5 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- SIRT5 (Sirtuin 5 (SIRT5))
-
Autre désignation
- SIRT5
-
Sujet
- SIRT5 is included in class III of the sirtuin family which ischaracterized by a sirtuin core domain. Human sirtuins may function as intracellular regulatory proteins with mono-ADP-ribosyltransferase activity.
-
Poids moléculaire
- 33 kDa (MW of target protein)
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-